Literature DB >> 26041377

Body composition in prostate cancer patients: novel insights suggest diverse prognostic roles of lean and fat mass.

Jacob Uth1, Jesper Frank Christensen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26041377     DOI: 10.1007/s12020-015-0644-4

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  10 in total

1.  Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941.

Authors:  Charles Huggins; Clarence V Hodges
Journal:  J Urol       Date:  2002-07       Impact factor: 7.450

2.  Fracture types and risk factors in men with prostate cancer on androgen deprivation therapy: a matched cohort study of 19,079 men.

Authors:  Shabbir M H Alibhai; Minh Duong-Hua; Angela M Cheung; Rinku Sutradhar; Padraig Warde; Neil E Fleshner; Lawrence Paszat
Journal:  J Urol       Date:  2010-09       Impact factor: 7.450

Review 3.  Muscle dysfunction in cancer patients.

Authors:  J F Christensen; L W Jones; J L Andersen; G Daugaard; M Rorth; P Hojman
Journal:  Ann Oncol       Date:  2014-01-08       Impact factor: 32.976

Review 4.  Effects of exercise on tumor physiology and metabolism.

Authors:  Line Pedersen; Jesper Frank Christensen; Pernille Hojman
Journal:  Cancer J       Date:  2015 Mar-Apr       Impact factor: 3.360

5.  The fat body mass increase after adjuvant androgen deprivation therapy is predictive of prostate cancer outcome.

Authors:  Consuelo Buttigliero; Federica Vana; Valentina Bertaglia; Francesca Vignani; Cristian Fiori; Giangiacomo Osella; Francesco Porpiglia; Marcello Tucci; Giorgio Vittorio Scagliotti; Alfredo Berruti
Journal:  Endocrine       Date:  2015-01-15       Impact factor: 3.633

6.  Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL Study.

Authors:  Adriana Villaseñor; Rachel Ballard-Barbash; Kathy Baumgartner; Richard Baumgartner; Leslie Bernstein; Anne McTiernan; Marian L Neuhouser
Journal:  J Cancer Surviv       Date:  2012-10-04       Impact factor: 4.442

7.  Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer.

Authors:  Nancy L Keating; A James O'Malley; Matthew R Smith
Journal:  J Clin Oncol       Date:  2006-09-20       Impact factor: 44.544

Review 8.  Adverse effects of androgen deprivation therapy and strategies to mitigate them.

Authors:  Paul L Nguyen; Shabbir M H Alibhai; Shehzad Basaria; Anthony V D'Amico; Philip W Kantoff; Nancy L Keating; David F Penson; Derek J Rosario; Bertrand Tombal; Matthew R Smith
Journal:  Eur Urol       Date:  2014-08-02       Impact factor: 20.096

Review 9.  Mechanisms linking physical activity with cancer.

Authors:  Anne McTiernan
Journal:  Nat Rev Cancer       Date:  2008-03       Impact factor: 60.716

10.  Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study.

Authors:  Carla M M Prado; Jessica R Lieffers; Linda J McCargar; Tony Reiman; Michael B Sawyer; Lisa Martin; Vickie E Baracos
Journal:  Lancet Oncol       Date:  2008-06-06       Impact factor: 41.316

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.